{
  "timestamp": "20250104_051204",
  "model": "gpt-4-turbo",
  "interaction_type": "answer_with_enhancement_kg_only",
  "question_id": "85133175",
  "question_text": "Hyperprolactinemia is a side effect of",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on enhanced information."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.\n                    You are a medical expert determining the final answer.\n\n            ### Instructions:\n            - Use standard medical knowledge as the primary guide.\n            - Consider enhanced information only if it aligns with consensus.\n            - If conflicting or unclear, present the most likely correct answer based on known facts.\n            - It's acceptable to show moderate confidence if the question is complex, but still choose one best answer.\n\n\n                    ### Question\n                    Hyperprolactinemia is a side effect of\n\n                    ### Options\n                    opa. Bromocriptine\nopb. Levodopa\nopc. Amantadine\nopd. Metoclopramide\n\n### Enhanced Information (For Contextual Support):\nMetoclopramide, which blocks dopamine receptors, leads to increased prolactin release and is associated with hyperprolactinemia. Bromocriptine, levodopa, and amantadine, all of which increase dopamine activity or mimic its effects, are unlikely to cause hyperprolactinemia. This conclusion is supported by the pharmacological actions of these drugs and their interactions with dopamine and prolactin pathways.\n\n                    ### Task:\n                1. Identify the core medical principle and the most likely correct option based on consensus.\n                2. If the evidence is not perfectly clear, pick the best-supported option and explain the reasoning.\n                3. Provide a final analysis and a confidence score (0-100%).\n\n                ### Output Format:\n                {\n                  \"final_analysis\": \"Step-by-step reasoning, prioritizing medical consensus and acknowledging complexity if present.\",\n                  \"answer\": \"Option key (e.g. opa, opb, ...)\",\n                  \"confidence\": A number between 0-100\n                }\n                    "
    }
  ],
  "response": "### Core Medical Principle:\nHyperprolactinemia is a condition characterized by elevated levels of prolactin in the blood. Prolactin is a hormone produced by the pituitary gland, and its secretion is primarily inhibited by dopamine. Drugs that interfere with dopamine pathways can therefore influence prolactin levels.\n\n### Analysis of Options:\n- **Bromocriptine (opa)**: This drug is a dopamine agonist, meaning it mimics the action of dopamine. It is typically used to decrease prolactin levels and would not cause hyperprolactinemia.\n- **Levodopa (opb)**: As a precursor to dopamine, levodopa increases dopamine levels in the brain and would not typically lead to hyperprolactinemia.\n- **Amantadine (opc)**: This medication increases dopamine release and also has antiviral properties. It is not commonly associated with causing hyperprolactinemia.\n- **Metoclopramide (opd)**: This drug is a dopamine receptor antagonist, which means it blocks the action of dopamine. By inhibiting dopamine's prolactin-lowering effect, metoclopramide can lead to increased prolactin levels, thus causing hyperprolactinemia.\n\n### Final Analysis:\nBased on the pharmacological actions of the drugs listed, metoclopramide is the most likely to cause hyperprolactinemia. This conclusion aligns with the standard medical understanding of the relationship between dopamine activity and prolactin secretion. Metoclopramide's role as a dopamine antagonist directly contributes to elevated prolactin levels by preventing dopamine from exerting its inhibitory effect on prolactin release.\n\nGiven the clear mechanism of action and the consensus in medical literature regarding the side effects of metoclopramide, there is a high degree of confidence in this conclusion.\n\n```json\n{\n  \"final_analysis\": \"Metoclopramide, as a dopamine antagonist, inhibits the normal inhibitory effect of dopamine on prolactin secretion, leading to hyperprolactinemia. This aligns with the known pharmacological effects of the drug and is supported by medical consensus.\",\n  \"answer\": \"opd\",\n  \"confidence\": 95\n}\n```",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": true,
    "has_enhanced_info": true,
    "model_config": "gpt-4-turbo",
    "temperature": 0.0
  }
}